Guide · Long term · 3 min read
If you stop the medicine
While the medicine is continued, the lower weight was kept for at least 4 years in studies. 3 When it is stopped, weight regain is common: up to two-thirds of the lost weight comes back within a year. 3 This was seen even with nutrition counselling or behavioural therapy. 3
What the studies show
- Tirzepatide (SURMOUNT-4): after 36 weeks on tirzepatide, people who switched to placebo regained 14.8% of their weight over the next 52 weeks, while those who continued lost a further 6.7%. 1 Even so, the placebo group's average weight at the end was still below where they started. 1
- Semaglutide (STEP 1): in the year after stopping, weight went up in both groups, but it stayed 5.6% below the starting weight in the semaglutide group, compared with 0.1% in the placebo group. 2
Plan it with your doctor
- Don't stop your medicine without talking to your doctor. 2
- There is no proven plan yet: whether a more structured nutrition and lifestyle programme can limit regain after stopping has not been tested in controlled trials. 3
Habits that matter
- Strength and activity: the NHS suggests strengthening activities on at least 2 days a week and at least 150 minutes of moderate activity a week. 4
- Food: the Advisory recommends more minimally processed, nutrient-dense foods and fewer starch- and sugar-rich ultraprocessed foods. 3
- Less sitting: break up long periods of not moving with some activity. 4
In CalJab
If you keep logging your weight, Body shows your weekly change and marks a plateau. Your protein target and How are you stay the same. Your doctor report shows your weight and doses together, which helps when you talk about stopping.
Decide on stopping or changing your medicine together with your doctor.
Sources
- 1Mounjaro product information and package leaflet. European Medicines Agency (EMA). Accessed 20 October 2026. ema.europa.eu
- 2Wegovy product information and package leaflet. European Medicines Agency (EMA). Accessed 20 October 2026. ema.europa.eu
- 3Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity 2025;33(8):1475-1503. pmc.ncbi.nlm.nih.gov
- 4NHS: Physical activity guidelines for adults aged 19 to 64. Last reviewed 22 May 2024. nhs.uk
Written by the CalJab team, with sources. It does not replace your doctor's advice. Found a mistake? Write to support@caljab.app.